Anakinra, a Recombinant Human IL-1 Receptor Antagonist, in Clinical Practice. Outcome in 60 Patients With Severe Rheumatoid Arthritis. Reumatismo 2007, 59 (1), 32-37. https://doi.org/10.4081/reumatismo.2007.32.